QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives

Ferreira, Glaucio Monteiro, Magalhães, Juliana Gallottini De, Maltarollo, Vinícius Gonçalves, Kronenberger, Thales, Ganesan, Arasu ORCID: https://orcid.org/0000-0003-4862-7999, Emery, Flávio Da Silva and Trossini, Gustavo Henrique Goulart (2020) QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives. Journal of Biomolecular Structure and Dynamics, 38 (2). pp. 354-363. ISSN 0739-1102

Full text not available from this repository. (Request a copy)


Sirtuin 2 is a key enzyme in gene expression regulation that is often associated with tumor proliferation control and therefore is a relevant anticancer drug target. Anilinobenzamide derivatives have been discussed as selective sirtuin 2 inhibitors and can be developed further. In the present study, hologram and three-dimensional quantitative structure–activity relationship (HQSAR and 3D-QSAR) analyses were employed for determining structural contributions of a compound series containing human sirtuin-2-selective inhibitors that were then correlated with structural data from the literature. The final QSAR models were robust and predictive according to statistical validation (q2 and r2pred values higher than 0.85 and 0.75, respectively) and could be employed further to generate fragment contribution and contour maps. 3D-QSAR models together with information about the chemical properties of sirtuin 2 inhibitors can be useful for designing novel bioactive ligands.

Item Type: Article
Uncontrolled Keywords: anilinobenzamide,coactivator,comfa,comsia,design,discovery,docking,gluconeogenesis,hqsar,ligand,models,potent,protein,validation,epigenetic,sirtuin
Faculty \ School: Faculty of Science > School of Pharmacy
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 08 Jul 2019 15:31
Last Modified: 21 Oct 2022 22:34
URI: https://ueaeprints.uea.ac.uk/id/eprint/71667
DOI: 10.1080/07391102.2019.1574603

Actions (login required)

View Item View Item